Dogwood Therapeutics DWTX
NASDAQ DWTX
$1.17 +0.02 (+1.74%)
At close: Oct 21, 2026 · 4:00 PM EDT

Dogwood Therapeutics (DWTX) Other financing activities (2020 - 2026)

Updated

Dogwood Therapeutics' Other financing activities was $17,029 in Q4 2020, up 32.1% from the prior quarter.

Analysis

Dogwood Therapeutics (DWTX) Other financing activities (2020 - 2026) Analysis & Trends

For FY2020, Other financing activities at Dogwood Therapeutics came in at $75,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Dogwood Therapeutics 39.59 Mn 100,954.34 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -106,266.00
Mar 31, 2021 -295,166.00
Dec 31, 2020 57,340.00
Sep 30, 2020 -115,520.00
API Access

Dogwood Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=DWTX&period=max&api_key=YOUR_API_KEY